CRISPR Therapeutics
Biotechnology & Life Sciences
Where
105 West First Street, South Boston, MA, 02127
Overview
CRISPR Therapeutics is a pioneering gene-editing company co-founded by Nobel laureate Emmanuelle Charpentier to translate CRISPR/Cas9 technology into transformative therapies. In partnership with Vertex Pharmaceuticals, the enterprise developed Casgevy, the world’s first approved CRISPR-based gene therapy for sickle cell disease and transfusion-dependent beta-thalassemia. By engineering ex vivo and in vivo cellular therapies, CRISPR Therapeutics advances precision genomic medicines for genetic disorders and immuno-oncology.